Home/Filings/4/0001144204-15-005665
4//SEC Filing

Adamis Pharmaceuticals Corp 4

Accession 0001144204-15-005665

CIK 0000887247operating

Filed

Feb 2, 7:00 PM ET

Accepted

Feb 3, 6:51 PM ET

Size

9.3 KB

Accession

0001144204-15-005665

Insider Transaction Report

Form 4
Period: 2015-01-30
Transactions
  • Sale

    Common Stock, par value $0.0001

    2015-01-30$6.92/sh10,000$69,1701,705,388 total(indirect: See Footnote)
  • Sale

    Common Stock, par value $0.0001

    2015-02-03$6.67/sh20,000$133,3801,685,388 total(indirect: See Footnote)
Footnotes (2)
  • [F1]Represents shares of the Issuer's common stock held by Eses Holdings (FZE), a corporation organized under the laws of Sharjah, United Arab Emirates ("Eses"). Ahmed Shayan Fazlur Rahman is the sole shareholder of Eses, and possesses the power to vote and the power to direct the disposition of all securities of the Issuer held by Eses.
  • [F2]Represents the sale of 20,000 shares in 5 separate transactions, ranging from $6.6192 to $6.7517 per share, resulting in a weighted average sale price per share of $6.6690. The Reporting Persons undertake to provide upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Issuer

Adamis Pharmaceuticals Corp

CIK 0000887247

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000887247

Filing Metadata

Form type
4
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 6:51 PM ET
Size
9.3 KB